Skip to main content
. 2018 Apr 19;9(10):1737–1744. doi: 10.7150/jca.24836

Figure 3.

Figure 3

Comparison of SUVmaxBM in different groups. A, non-MI group (N=63). B, MI group (N=21). C, Patients diagnosed with LPL/WM, multiple myeloma and CML in MI group (N=9). D. Other patients in MI group (N=12).